SELARL PHARMACIE DES MAISONS BLANCHES : revenue, balance sheet and financial ratios

SELARL PHARMACIE DES MAISONS BLANCHES is a French company founded 14 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-CYR-SUR-LOIRE (37540), this company of category PME shows in 2023 a revenue of 1.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DES MAISONS BLANCHES (SIREN 750304826)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C 1 189 786 € 1 079 503 € N/C N/C 942 086 € N/C N/C N/C
Net income 40 259 € 93 950 € 56 624 € 62 597 € 66 836 € 50 830 € 53 929 € 43 434 € 51 229 €
EBITDA N/C 74 617 € 65 250 € N/C N/C 67 184 € N/C N/C N/C
Net margin N/C 7.9% 5.2% N/C N/C 5.4% N/C N/C N/C

Revenue and income statement

In 2024, SELARL PHARMACIE DES MAISONS BLANCHES generates positive net income of 40 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 51 k€ -> 40 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

40 259 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 15%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 73%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

15.182%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

73.303%

Solvency indicators evolution
SELARL PHARMACIE DES MAISONS BLANCHES

Sector positioning

Debt ratio
15.18 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent

In 2024, the debt ratio of SELARL PHARMACIE DES MAIS... (15.18) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
73.3% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent +7 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE DES MAIS... (73.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.62 years 2023
2022
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Excellent -8 pts over 2 years

In 2023, the repayment capacity of SELARL PHARMACIE DES MAIS... (0.62) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE DES MAISONS BLANCHES

Positioning of SELARL PHARMACIE DES MAISONS BLANCHES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE DES MAISONS BLANCHES is estimated at 562 045 € (range 391 399€ - 840 852€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
391k€ 562k€ 840k€
562 045 € Range: 391 399€ - 840 852€
NAF 5 année 2024

Valuation method used

Net Income Multiple
40 259 € × 14.0x = 562 045 €
Range: 391 400€ - 840 852€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DES MAISONS BLANCHES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DES MAISONS BLANCHES

What is the revenue of SELARL PHARMACIE DES MAISONS BLANCHES ?

The revenue of SELARL PHARMACIE DES MAISONS BLANCHES in 2023 is 1.2 M€.

Is SELARL PHARMACIE DES MAISONS BLANCHES profitable?

Yes, SELARL PHARMACIE DES MAISONS BLANCHES generated a net profit of 40 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE DES MAISONS BLANCHES ?

The headquarters of SELARL PHARMACIE DES MAISONS BLANCHES is located in SAINT-CYR-SUR-LOIRE (37540), in the department Indre-et-Loire.

Where to find the tax return of SELARL PHARMACIE DES MAISONS BLANCHES ?

The tax return of SELARL PHARMACIE DES MAISONS BLANCHES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DES MAISONS BLANCHES operate?

SELARL PHARMACIE DES MAISONS BLANCHES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.